The study demonstrated that alternative splicing is the mechanism by which KAI1 undergoes downregulation in advanced cases of breast cancer because truncated/spliced KAI1 was correlated with more advanced cases of breast cancer. The gene discussed is CD82; the disease is breast carcinoma.